UNG2 deacetylation confers cancer cell resistance to hydrogen peroxide-induced cytotoxicity

Area of Science:

• Molecular Biology
• Cancer Research
• Biochemistry

Background:

• Cancer therapeutics generate reactive oxygen species (ROS) that damage cancer cell DNA, aiming to induce cell death.
• Cancer cells possess resistance mechanisms against ROS-induced cytotoxicity, contributing to treatment failure.

Purpose of the Study:

• To investigate the role of nuclear-localized uracil-DNA N-glycosylase isoform 2 (UNG2) in cancer cell resistance to ROS-induced DNA damage.
• To explore a novel therapeutic strategy combining HDAC inhibitors and genotoxic agents for enhanced cancer cell killing.

Main Methods:

• Investigated the stability and function of UNG2 in cancer cells under ROS exposure.
• Examined the interaction between UNG2 and the E3 ligase UHRF1, and the role of acetylation and histone deacetylases (HDACs).
• Evaluated the synergistic effect of combining HDAC inhibitors with genotoxic agents on cancer cell viability in vitro.

Main Results:

• UNG2 prevents ROS-induced DNA damage and confers resistance to cancer cells.
• ROS exposure extends UNG2 half-life by preventing its degradation via the UHRF1 ligase, mediated by deacetylation at lysine 78.
• Combining HDAC inhibitors with genotoxic agents resulted in a significant synergistic killing effect on cancer cells.

Conclusions:

• Nuclear UNG2 plays a critical role in enabling cancer cell survival under ROS-inducing conditions.
• Targeting UNG2 degradation through HDAC inhibition presents a promising novel approach for cancer therapy.
• This strategy enhances the efficacy of genotoxic cancer therapeutics by overcoming cancer cell resistance mechanisms.